Archive for the ‘China Stock Market’ Category

Chinese shares jumped 3 percent on Friday

Chinese shares jumped 3 percent on Friday,We all remember chinese index plunged 15 persent in last week,And I had said there have some money to earn in the market if index sharply drop again,now it is time to do some day-trader.I had buy some security company like “600030″,the biggest company in china security industry,today it return 9% profit to me,:-).But I had to say I don’t know is it really a “V trend” which worth to plunge into all of your financel capital.

OK,there have  some shares falling again,mainly is airline company,because government announcemen they will lift the prices of oil,electricity on Thursday evening.But financel companies and oil companies jumped stongly.

4th round of China-U.S. Strategic Economic Dialogue

written by chinainvestor.net
06.18.2008,In 4th round of China-U.S. Strategic Economic Dialogue,minister-level officials from the two governments shared views on global economic and financial problems.Chinese Vice Premier Wang Qishan and U.S. Secretary of Treasury Henry Paulson agree to start talks on bilateral investment pact,And exchanged views on oil price,then signed a 10-year energy and environment cooperation framework.This dialogue is make by paulson,and let China and U.S. can expression their views on economic of each other.This is the first time Chinese Vice Premier Wang QIshan appeared this meet,and him will lead chinese officials in SEO next years.

Although there have some achievement in the 4th round of SEO,but stock marketof USA and China forward south again.Chinese shanghai stock index sharply plunged 3.37 percent at afternoon of 06-19-2008,And there have a 1.08 percent come down at DOW too.I thinks there will have some chance to earn some little money if index fell sharply again.

Chinainvestor.net:All people hurt by weak chinese stocks

China investor.net:China stocks finish sharply lower at Fri,plunged 15 percent a week,finish FRI session at 2865,All people hurt by weak chinese stocks.Now the PE of china 300 stock index is 21.82,low than USA 500 index which is 21.84 at FRI,This is the first time the valuation of china A-SHARE companies lower than USA companies since MARCH 2006.

But I think this is a chance to find out good companies which have high return and low quote.Maybe,if index sharply drop again,I will begin do some test to trade in chinese stock market.

Shenzhen Industrial Co., Chase Manhattan Corp. share-trading reform progress in the implementation of notice – Information Centre – Finance

The company's board of directors of all members of the contents of the notice true, accurate and complete, no false records, misleading statements or major omissions.

The Company was April 22, 2008 held a share-trading reform of the 2008 first interim general meeting of shareholders, the convening of this meeting and the convening procedures, to attend the shareholders and现场会议qualified nominee shareholders meeting and voting procedures, and the company The Board commissioned by the assembly voting procedures and other related matters, in compliance with the relevant share-trading reform of the laws, regulations, the provisions of this meeting to consider the motion is passed, this meeting results of the vote valid. The general meeting of shareholders of the voting result, the company has been published in the April 24, 2008's "China Securities News" and the giant tidal information network (www.cninfo.com.cn).

As part of the shares of companies still frozen, unable to register shares are now part of the shares of the work is being unfreezing of the relevant parties actively promote the cooperation, the Company will work in accordance with the progress of a timely manner with their information disclosure obligations.

Please investors pay attention to investment risks.

It is hereby announced.

Shenzhen Industrial Co., Chase Manhattan Corp. Board of Directors

June 3, 2008 China Securities News

Henan Ancaigaoke Co., Ltd. held on the 2007 annual shareholder meeting notice – Information Centre – Finance

Board of Directors of the Company and all members of the contents of the notice true, accurate and complete, the notice of false records, misleading statements or major omissions are jointly and severally liable.

Henan Ancaigaoke Corp. for the recently held 2007 annual shareholders meeting, matters related to notice as follows:

First, meeting basic conditions:

1, holding time: 2008 6月26日(Thursday) at 9:30

2, Venue: Anyang City of Henan Province Zhongzhou southern section companies on the 4th Conference Room

3, Convenor: Henan Ancaigaoke Corp. Board of Directors

4, held by: the scene vote

Second, the Conference considered:

1, "2007 annual report on the work of the Board of Trustees"

2, "2007 annual report on the work of the board of supervisors"

3, "2007 annual report and summary"

4, "2007 Provision for impairment of assets of the report"

5, "on the company's motion to change accounting estimates"

6, "on the 2007 opening balance sheet and its related projects amount to change or adjust the motion"

7, "2007 annual financial report of the accounts"

8, "2007 annual profit distribution plan"

9, "2008 is expected to report daily the transactions"

The motion has more than 10 companies at its third meeting of the Board of Trustees and third consideration of the seventh meeting of the board of supervisors adopted, see notice on March 29, 2008 of the "Shanghai Securities News."

Third, to attend the meeting are:

1, the company directors, supervisors and senior management personnel;

2,2008, 6月19日(星期四) 15:00 at the end of trading, the China Securities Clearing Company Limited Shanghai Branch of the registered shareholders of the Company;

3, to accept the conditions (2) the shareholders of Representative Is Appointed.

4. Registration for the meeting:

1, have qualified to attend the meeting of the individual shareholders holding my ID card, such as shareholder equity that card account; corporate shareholders authorized a legal power of attorney (with official seals), the shareholder account cards, identity cards and who attended a copy of the business license ( Chapter covered companies); nominee shareholders holding personal identity, the donor card accounts and shareholders authorized power of attorney, letter or fax can be used in the June 24, 2008 (8:30-11:30 am; 2:30 pm -4:30) For the registration of the report procedures. We do not accept telephone registration.

2, contact:

Address: Department of Henan Ancaigaoke Securities Co., Ltd. Zip code: 455000

Phone: (0372) 3932916 to 2533 Fax: (0372) 3938035

5, other issues: transportation to attend the meeting of shareholders, board and lodging at their own expenses.

It is hereby announced.

Henan Ancaigaoke Corp. Board of Directors

June 4, 2008

Annex: authorized power of attorney forms (copy or use the following format are effectively home-made)

Authorized power of attorney

It is commissioned by the President (President) on behalf of the unit (I) at the Henan Ancaigaoke Corp. 2007 annual shareholders meeting, took the exercise of the right to vote.

Trustor (signature or seal): client ID number:

Principal shareholder accounts: principal holders of shares:

Trustee (signature or seal): identity of the trustees:

Consideration of matters on the client's instructions:

A motion: Yes â–¡ â–¡ opposition abstained â–¡

Second motion: Yes â–¡ â–¡ opposition abstained â–¡

Third motion: Yes â–¡ â–¡ opposition abstained â–¡

Fourth motion: Yes â–¡ â–¡ opposition abstained â–¡

5 motion: Yes â–¡ â–¡ opposition abstained â–¡

6 motion: Yes â–¡ â–¡ opposition abstained â–¡

7 motion: Yes â–¡ â–¡ opposition abstained â–¡

8 motion: Yes â–¡ â–¡ opposition abstained â–¡

9 motion: Yes â–¡ â–¡ opposition abstained â–¡

Date: Effective date:
China Securities News

Hunan Province of China Chemical Industry Development Co., Ltd. days on the transfer of day-run transport facilities Yueyang Limited shares of the notice – Information Centre – Finance

The company and its directors, supervisors and senior managers ensure that notices are true, accurate and complete, and notice of false records, misleading statements or omissions major responsibility.

Companies in the November 18, 2007 at the 10th meeting of the Board of Trustees at its seventh examined and adopted the "sell on the day-run transport facilities Yueyang limited liability company owned motion", to agree to holding subsidiaries Yueyang days Run transport facilities Limited ( Hereinafter referred to as "day-run traffic") 98.25 percent stake in all transferred to the infrastructure of Yueyang City Road and Bridge Corporation (hereinafter referred to as the "bridge"), will now notice the implementation of the resolution are as follows:

First, the transfer of equity outlined

Run-day traffic is a subsidiary company, was established in August 2002, the registered capital of 285 million yuan, the company invested 2,800 million, representing 98.25 percent stake in the company invested 500,000 yuan bridge, or 1.75 percent stake, mainly in roads and bridges and other transport facilities on the manufacture and installation. In order to expand the main focus on industry, the company decided to transfer all the shares held by the company to bridge the two sides on November 27, 2007 signed the "Equity Transfer Agreement," the agreement agreed:

1, the company will hold its Run-traffic days of the 98.25 percent stake in all transferred to the Road and Bridge Company, and since December 1, 2007, will be transferred to its control of the bridge, no longer involved in day-run traffic The financial and operational decision-making, dependent on equity to all the rights and obligations enjoyed by the Road and Bridge Corporation and commitment;

2, agreed to by the public and the southern Shenzhen accounting firm auditing the November 30, 2007 Run-traffic days of the net assets of equity transfer pricing basis;

Shenzhen public and the accounting firm auditing the South, ended November 30, 2007 Run-traffic days of the net assets of: 3,359.54 million, attributable to the interests of the shareholders of the company: 3,300.75 million. After consultation between the two sides finalized the transfer of shares price of RMB 3,400 million, the proceeds of the transactions 992,500 yuan;

3, since the agreement was signed on the date of road and bridge in the May 31, 2008, pay the full transfer.

Second, the share transfer progress

1,2007, the November 27 signing of the "Equity Transfer Agreement";

2,2008, April 29 companies received the first transfer of 30 million shares;

3,2008, May 30 the company received a second transfer of shares of 4 million yuan, thus, the company has received all the stock transfer of 3,400 million;

4, the two sides agreed in the July 30, 2008 for End Run-traffic days of the industrial and commercial registration procedures for change.

It is hereby announced.

Hunan-day development of China Chemical Co., Ltd.

June 3, 2008 China Securities News

Health yuan Pharmaceutical Group Co., Ltd. shareholders equity pledge to lift notice – Information Centre – Finance

Securities: health yuan securities code: 600380 Notice Number: A 2008-018

Health yuan Pharmaceutical Group Co., Ltd.

Shareholders equity pledge to lift Notice

Shenzhenshibai industry source of investment loans pledged Limited, in the March 16, 2006, the Company will hold 339,322,500 shares sponsors of 40,000,000 shares shares (because April 23, 2007 To implement the 2007 profit distribution programme, after the pledge Song Gu Gu Shuwei 72,000,000 shares), pledge to the Huaxia Bank Co., Ltd. Shenzhen high-tech branch.

Shenzhenshibai industry sources Investment Limited was on June 2, 2008 lifting of the above pledge.

It is hereby announced.

Health yuan Pharmaceutical Group Co., Ltd.

June 3, 2008 China Securities News

Shanghai Qiangsheng Holding Co., Ltd. eighth meeting of the Board of Trustees of the sixth meeting of the Provisional Notice 2007 and held the company's annual shareholder meeting notice – Information Centre – Finance

May 22, 2008, the company by letter and e-mail to inform the Board of Trustees held its sixth meeting of the provisional eighth, June 2, 2008 to communications companies held a meeting attended by directors to be nine people, is to 9, company law and corporate charter in line with the relevant provisions. Meeting considered and unanimously adopted the following resolution:

1, to amend the Articles of Association of resolution.

The original: "Article 19 of the company approved the issuance of ordinary shares to the total number of shares 62579.9244. Which limited the sale of company shares outstanding conditions for 20720.2094 million, accounting for 33.11 percent of all of the shares, unlimited shares for sale conditions 41859.7150 million shares, accounting for all of the shares of 66.89 percent. "

Is amended to read: "Article 19 of the company approved the issuance of ordinary shares to the total number of shares 62579.9244. Which limited the sale of the company conditions for 20345.8307 million shares of common stock, representing all of the shares of 32.51 percent, the unlimited flow of conditions of sale 42234.0937 million for the shares, accounting for all of the shares of 67.49 percent. "

2, 2007 on the convening of the company's annual shareholders meeting resolution. The matter will now notice the following:

1, the meeting: June 27, 2008 9:30 am

Second, the meeting place: Shanghai Road 306, Taixing City CPPCC cultural clubs Qunlou

Third, the meeting agenda:

1) Company 2007 annual report on the work of the Board of Trustees

2) the company 2007 annual report on the work of the board of supervisors

3) The company reports 2007 annual financial accounts

4), the 2007 profit distribution plan

5) 2008 annual renewal of Shanghai will accounting firm's motion

6) amending the articles of incorporation

7) expects 2008 daily transactions related motion

Fourth, the meeting: the scene

5, attended the target

(1) of company directors, supervisors and senior management

(2) The deadline for June 18, 2008 at 15:00 after the end of trading, the China Securities Depository Clearing Co. Ltd. Shanghai Branch of the registered shareholders of the Company or its legal commission agents have the right to participate in this general meeting of shareholders.

(3) the company's lawyers to witness the appointment of staff.

6, the Conference Registration

(1) Registration date: June 20, 2008 (9:00-11:30 am 13:00-15:30 pm)

(2) registration locations: Shanghai, Nanjing West Road 920

(3) The registration procedure: social corporate shareholders, a unit recommendation letters, legal persons authorized power of attorney, shareholders account cards for registration; flow of shareholders holding my ID card, shareholders account cards, Representative Is Appointed holding power of attorney is authorized to commission And the agent identity, the principal shareholder accounts card to register at the same time accept the shareholders with a letter or fax to register.

(4) Company Contact: Shanghai, Nanjing West Road, Room 920, 1808

Zip Code: 200041

Tel: (021) 62152699

Fax: 021 * 62538782

Contact: Jin Yan

(5) of this meeting a half-day session, participants board and lodging and travel expenses themselves.

(6) According to the Shanghai Zheng Jianju "on the maintenance of the city listed company shareholders meetings of the Conference of the order of the notice", this general meeting of shareholders not to the shareholders of gifts, please attend the meeting of the shareholders of understanding.

By-laws: authorized power of attorney

Authorized power of attorney

It is fully commissioned by the President (President) on behalf of my unit (personal) at the Shanghai Qiangsheng Holding Co., Ltd. 2007 annual shareholders meeting.

Names of clients: client ID number:

Principal shareholders: the stock client card account number:

Trustee Name: trustees identity card numbers:

Entrusted with the date: client signature (Seal)

It is hereby announced

Shanghai Qiangsheng Holding Co., Ltd.

Second OO June 4 2008 China Securities News

Shanxi Asia-Pharmaceutical Group Co., Ltd. – Information Centre – Finance

Securities Code: 600351 Stock code: Asia-industry code: 2008 – Council on the 13th

Shanxi Asia-Pharmaceutical Group Co., Ltd.

22 of the third meeting of the Board resolution

Notice and the convening of the 2007 annual shareholder meeting notice

Board of Directors of the Company and all the members of the contents of the notice true, accurate and complete, the notice of false records, misleading statements or major omissions are jointly and severally liable.

Shanxi Pharmaceutical Group Co., Ltd. Asia-third in the 22nd meeting of the Board of Trustees on June 3, 2008 in Fenglingdu Development Zone Company headquarters conference room held, the meeting should go to directors of 11 people, is the director of 11 , In line with the "Company Law" and "Articles of Association" the relevant provisions. Supervisors of the Company and some executives attended the meeting as observers. , Chairman of the meeting by Mr. Ren Wuxian chair, the meeting considered and adopted by consensus without a vote the following resolution:

First, consider the adoption of changes to registered capital of the company's motion;

Due to the successful issuance of RMB 2511.3 million shares of common stock, the registered capital of the company from 133.125 million yuan change to 158.238 million yuan.

Second, to consider the adoption of the motion to amend the articles of incorporation;

Company in accordance with the relevant laws and regulations combined with the practical, it is proposed to the company's constitution to do the following modifications:

1, the original "Article 6 of companies registered capital of 133.125 million yuan."

Amended to read: "Article 6 of companies registered capital of 158.238 million yuan."

2, the original "Article 13 of the company registration office of Shanxi Administration of Industry and Commerce approved, the company business scope is: the production and sale of pharmaceutical raw materials, small volume injection, tablets, hard capsules, granules, tea agent, Oral Solution , Ointment, health supplies, sanitation materials, pharmaceutical packaging materials, plastic products; Chinese herbal medicine processing plant; operating the business of production for export products business, management of the enterprise for production of raw and auxiliary materials, instruments, machinery equipment, Spare parts and technology import and export business (national limited company and the state ban on the export of goods and technologies); feed processing operation and the "three to fill a" business; production of transdermal (based on registration with the Trade and Industry) . "

Amended to "Article 13 of the legally registered, the company operating range: the production and sale of pharmaceutical raw materials, small volume injection (with anticancer drugs), freeze-dried powder (containing anticancer drugs), opiates (including external), the hard capsules , Soft capsules, granules, tea agent, oral solution, ointment, psychotropic substances (chlorine nitrogen Zhuo, Diazepam tablets), transdermal, Babu preparation, health supplies, medical equipment, feed additives, health materials , Pharmaceutical packaging materials, plastic products, daily cosmetics, chemical products (except for dangerous goods). Cultivation of Chinese medicinal materials processing. Medicine in the research and development. Medical information consulting services and technology transfer. Enterprises operating in this production for the export business ; Operation of the enterprise for production of raw and auxiliary materials, instruments, machinery equipment, spare parts and technology import business (national limited company and the state ban on the export of goods and technologies); feed processing operation and the "three to one – "Business. (Companies operating in the scope of laws and regulations subject to the approval of the project, in accordance with the law should be approved, the actual scope of business to business registration, whichever is)."

3, the original "Article 19 of the company a total of 133.125 million shares, the company's capital structure: 13312.5 million shares of common stock."

Amended to "Article 19 of the company a total of 158.238 million shares, the company's capital structure: 15823.8 million shares of common stock."

4, the original "Article 28 of the sponsors of the holders of the shares of the Company since the date of the establishment of the company within one year shall not be transferable. Public offering of shares before the company issued the shares, since stock is listed on stock transactions in the day 1 During the year shall not be transferable.

Company directors, supervisors, senior management should be to declare the company held by the company's shares and their changes over time, the incumbents during the annual transfer of the shares they hold no more than the total number of shares of the Company's 25% held by the company since the shares of the Company Listed on the stock on the date of one year shall not be transferable. After the departure of six months, it shall not transfer the holders of the shares of the Company. "

Amended to "Article 28 of the sponsors of the holders of the shares of the Company since the date of the establishment of the company within one year shall not be transferable. Public offering of shares in the company before the shares issued, since the shares listed on stock transactions from the date of one year. Shall not be transferable.

Company directors, supervisors, senior management should be to declare the company held by the company's shares and their changes over time, the incumbents during the annual transfer of the shares they hold no more than the total number of shares of the Company's 25% held by the company since the shares of the Company Listed on the stock on the date of one year shall not be transferable. After the departure of six months, it shall not transfer the holders of the shares of the Company.

State laws and regulations of the shareholders and Dong, supervisors, senior management of the transfer of the shares of the Company are the latest requirements, from its provisions. "

5, the original "Article 43 is one of the following cases, in fact from the day when two of shareholders held within the General Assembly:

(A) the number of directors less than the "Company Law" provisions of the statute or by the number of 2 / 3; "

Amended to "Article 43 is one of the following cases, in fact from the day when two of shareholders held within the General Assembly:

(A) the number of directors less than the number set by the statute of the 2 / 3; "

6, the original "Article 67 shareholders meeting presided over by the chairman. Chairman unable to perform his functions or not to perform his functions, from vice chairman of the board (the two companies have two or more vice chairman of the board, from more than half of the directors nominated jointly Vice chair), Chairman, vice chairman of the board is unable to perform their duties or do not fulfil their duties, the directors shared by more than half of one of the directors elected chair "

Amended to "Article 67 shareholders meeting presided over by the chairman. Chairman unable to perform his functions or not to perform his functions, chaired by the vice chairman, vice chairman of the board is unable to perform their duties or do not fulfil their duties, by more than half of the directors elected a common Directors chair. "

7, the original "99 directors of two consecutive failed to personally attend, nor commissioned by the other directors to attend meetings of the Board and deemed unable to perform duties, the Board should recommend to shareholders of the General Assembly to be replaced."

Amended to "99 directors of two consecutive failed to personally attend, nor commissioned by the other directors to attend meetings of the Board and deemed unable to perform duties, the Board should recommend to shareholders of the General Assembly to be replaced.

By holders of more than 3% stake in the company's shareholders nomination and election of directors, during his term of office, his nomination by the shareholders of the company shares shall not be less than 3 percent for companies to expand their lead to the nomination of equity shares held by shareholders less than 3 percent, Its shareholders not to nominate the reduction of the shares held by the company, otherwise the board the right to be brought to the general meeting of shareholders to replace the directors nominated by the shareholders. "

8, the original "Article 106 of the Board of Trustees from 11 directors, one for chairman, vice chairman of the board 2. Board members of the staff representatives of a people."

Amended to "Article 106 by the board of directors composed of nine directors, the chairman of an established, vice chairman of the board one. Members of the Board of Directors on behalf of two employees."

9, in the original article 110, "the board decided the company accounted for the most recent audited net assets below 50 percent or 50 million yuan in the absolute amount of foreign investment following the acquisition sale of assets, asset-backed, trust management; decision in the amount of 30 million yuan of the company or the most recent audited net assets of five percent below the absolute value of the transactions. "

Amended to "the board decided the company accounted for the most recent audited net assets of less than 25% of foreign investment, acquisition, sale of assets, asset-backed, trust management; decision of the companies most recent audited net assets of five percent below the absolute value of the transactions . "

10, the original "111, chairman of the board of directors established one, the vice chairman of the board two. Chairman and vice chairman of the board of directors by the board of directors to a majority of all elected."

Amended to "Article 111, chairman of the board for one person, one vice chairman. Chairman and vice chairman of the board of directors by the board of directors to a majority of all elected."

11, the original "Article 113 of the company chairman, vice chairman of assistance, chairman unable to perform his functions or do not fulfil their duties, the vice chairman of the board from performing their duties (the two companies have two or more vice chairman of the board, from More than half of the elected co-vice chairman of the board of directors performing their duties), vice chairman of the board is unable to perform duties or failure to perform duties from more than half of one of the directors nominated jointly carry out its duties. "

Amended to "Article 113 of the company chairman, vice chairman of assistance, chairman unable to perform his functions or do not fulfil their duties, the vice chairman of the board from performing their duties, the vice chairman of the board is unable to perform their duties or do not fulfil their duties, by more than half of directors One of the directors nominated jointly carry out its duties. "

12, the original Article 124 of the terms "company deputy general manager of five, the appointment or dismissal by the board of directors."

Amended to "work according to company vice president needs a 3-6, and the appointment or dismissal by the board of directors."

13, the original ? 143rd in terms of the "company board of supervisors. By the board of supervisors composed of five supervisors, the board of supervisors established a President, Vice-Chairman 1. Chairman and Vice-Chairman of the board of supervisors by a majority of the board of supervisors election. Chairman of the board of supervisors meeting and Chaired the board of supervisors meeting; Board of Supervisors President is unable to perform their duties or do not fulfil their duties, by the vice chairman of the board of supervisors to convene and chair the board of supervisors meeting; vice chairman of the board of supervisors is unable to perform their duties or do not fulfil their duties, by more than half of Supervisors elected a board of supervisors jointly convened and chaired the board of supervisors meeting. "

Amended to "company board of supervisors. By the board of supervisors composed of three supervisors, Chairman of the board of supervisors established one. Chaired by the board of supervisors elected by a majority of the board of supervisors. Chairman of the board of supervisors to convene and chair the board of supervisors meeting; Board of Supervisors President is unable to perform their duties or do not fulfil their duties, More than half of Supervisors elected a board of supervisors jointly convened and chaired the board of supervisors meeting. "

Third, to consider the adoption of amendments to the motion system of independent directors;

See the Shanghai Stock Exchange Web site (www.sse.com.cn).

4, to consider the adoption of additional fund-raising account for the motion;

Agreed in the original fund-raising special account (three terms of 17 considered by the Board of Trustees) on the basis of an additional fund-raising special account as follows:

Everbright Bank of China Beijing Branch of Changhong Qiao: 35200188000066890.

5, to consider the adoption of the Beijing Asia-Bio-Pharmaceutical Co., Ltd. replenishment of the motion;

The company agreed to Beijing Asia-Bio-Pharmaceutical Co., Ltd. replenishment of 70 million yuan, the replenishment is completed, Beijing Asia-Bio-Pharmaceutical Co., Ltd. registered capital of 80 million yuan, a wholly owned subsidiary.

6, considered by the Board of Trustees general election on the motion;

After the third board of directors of the Company on May 26, 2005 at the 2004 annual general meeting of shareholders elected for a term of three years, is now the expiration of the term, according to company law and the relevant provisions of the articles of incorporation, should be changed, with the relevant staff representation Eligible for review, the nomination of Wu Xian, Bo Shao-wei, Liu Chongxing, Yue Lihua, Feng Chen, Zhang Cheng, Liu Junyan, Zhao Henglin for the company board of directors of the fourth candidate, Feng Chen, Zhang Cheng , Liu Junyan, Zhao Henglin as an independent director candidates. The fourth candidate to be submitted to the Board of Directors of the firm's 2007 annual general meeting of shareholders for adoption. Independent director candidates to be audited on the Shanghai Stock Exchange no objection to the company before the 2007 annual general meeting of shareholders to consider.

(Director of curriculum vitae of the candidate see annex II)

More than 1, 2, 3, 6, 2007 motion required the company to submit annual general meeting of shareholders for adoption.

7, examined and adopted on the convening of the company's 2007 annual shareholder meeting motion.

(A) held a meeting basic conditions

1, convener of the meeting: Shanxi Asia-Pharmaceutical Group Co., Ltd. Board of Directors

2, the meeting: June 26, 2008 9:30 am

3, the meeting place:

Shanxi Asia-Pharmaceutical Group Co., Ltd. Headquarters Conference Room (in Shanxi Province Industrial Road Fenglingdu Economic Development Zone 1).

4, the meeting: The general meeting of shareholders to vote the way the scene to take hold.

(B) the consideration of matters

1, considered the "2007 annual report on the work of the Board of Trustees";

2, considered the "2007 Annual report on the work of the board of supervisors";

3, considered the "2007 annual financial report of the accounts";

4, to consider "profit distribution plans for the year 2007";

5, considered the "2007 annual report and summary";

6, considered "on the renewal of the letter and is the company's financial-based accounting firm audit the motion";

7, to consider "on the changes registered capital of the company's motion";

8, to consider "the motion on amending the charter company";

9, considered "independent director system of work on the revision of the motion";

10, considered the "general election on the Board of motion";

11, considered the "general election of the board of supervisors on the motion";

More than 1, 3, 4, 5, 6 motion by the three companies considered by the Board of Trustees 20; second motion by the three companies considered by the board of supervisors, 10; 7, 8, 9, 10 motion by the company Three of the 22 board of directors for consideration and approval; 11st motion by the three companies considered by the board of supervisors 12.

(C) qualified staff to attend

1,2008 in the afternoon of June 20 after the end of trading, the China Securities Clearing Company Limited Shanghai Branch registered to attend the meeting and for the registration of all the shareholders of the company, shareholders can Representative Is Appointed attended the meeting and participate in the voting.

2, none of the directors, supervisors and senior managers and lawyers to witness.

(D) of the registration

1, registration: June 25, 2008 9:00-16:00

2, registration: corporate shareholders shareholders account card holders, the legal representative power of attorney, copies of business licenses (legal entities stamping its official seal) and identity cards to register people to attend; individual shareholders holding shareholder accounts cards, identity cards for himself Registration; Representative Is Appointed holding my ID card, authorized power of attorney (Annex 1), client identity, principal shareholder of the registration card account; remote shareholders may be a letter or fax to register (to attend the meeting should be submitted to the above Original proof).

3, registration sites: Shanxi Asia-Pharmaceutical Group Co., Ltd. securities.

(5) business address and contact information

Address: Shanxi Province Fenglingdu Economic Development Zone Industrial Avenue on the 1st

Zip Code: 044602

Contact: Yang Kang

Tel :0359-3388071

Fax :0359-3388076

(6) other matters: duration of the day, the participating shareholders own transportation and room and board.

It is hereby announced

Shanxi Asia-Pharmaceutical Group Co., Ltd. Board of Directors

Second OO June 4 2008

Annex 1:

Authorized power of attorney

It is commissioned by the President (President) I attended on behalf of Shanxi Asia-Pharmaceutical Group Co., Ltd. 2007 annual general meeting of shareholders, and took the exercise of the right to vote of the full motion (if only on the authority of the motion please specify).

Trustor (signature): Trustee (Signed):

Client ID number: identity of the trustees:

Trustor stake: principal shareholder account:

Authorized Date:

Note: 1, the clients for corporate shareholders, legal entities should be stamping its official seal.

2, power of attorney newspaper clippings, copies of the format or self-made are valid.

Annex II:

First, director of curriculum vitae of the candidate:

Ren Wu Xian, male, 48 years old, postgraduates and senior engineer. National model workers, deputies of Shanxi Province. Pharmaceutical factory in Shanxi Province Ruicheng former chief of technology, technical deputy director, chief engineer and director; first session of the Board of the Company board chairman and general manager, the second Chairman of the Board. The current chairman, the party secretary.

Bo Siu-wai, male, 54 years old, college educated, registered accountants, certified public valuer, China registered cost engineer. A former state-owned industries in Datong City Accounting Office chief of the audit, the second audit by the Datong City, the Datong-chi, director of Friends of audit firms, economic development and investment companies in Shanxi Province, deputy chief accountant, the Company Board of Directors of the second session. Shanxi Province, currently vice president of economic development and investment companies; General Accountants Association of Shanxi Province, vice president; directors of the Company.

Liu Chongxing, male, 59 years old, college educated, researchers. A former NASA technician of the 062 bases 7102, and deputy director of the Shanxi Association for Science and Technology Information Centre deputy director of cadres, the first session of the Company, the second Vice Chairman of the Board. Current technology in Shanxi Province Development Corporation deputy general manager of the Fund, the secretary, vice chairman of the Company, also served as the Chinese Association and vice president of technology venture, the China Science and Technology Association for the Promotion of financial executive director of Fudan University, China Venture Capital Research Center researcher, is enjoying State Department experts and special allowances linked to the Shanxi Provincial Committee of high-level experts.

Yue Lihua, female, 55 years old, college educated, a senior economist. Former Taiyuan Iron and Steel company researcher at the Institute of Economic Research; Shanxi Province Economic and Trade Commission, Section officer, Deputy Commissioner; first session of the Company, the second session of the Board of Directors; Shanxi first three-dimensional, the second board of directors. Shanxi Province, the current trade and economic asset management limited liability company vice president, the vice chairman of the company; Shanxi Yuci Hydraulic Co., Ltd. directors.

Second, the independent directors of curriculum vitae of the candidate:

Feng Chen, male, 59 years old, college educated. Long engaged in economic management and economic research, had participated in the preparation of the "Industrial Economics and Management (teaching)", "China's industrial economic management", "China's industrial economic structure" and "political economics:" monographs, in "Chinese enterprises reported "A number of domestic financial newspaper published an article dozens category, as in the oil group, and so many large enterprises to co-ordinate the strategic management seminars and research, appointed by the Beijing Olympic Organizing Committee 2008 Olympic planning assessment experts.

The industrial economy was Chinese Academy of Social Sciences researcher at the Institute of attachment, the Beijing Arts and Crafts services manager, Party Branch secretary of the Beijing Arts and Crafts Assistant General Manager, director of the Institute of Tourism in Beijing, Hainan Airport Corp. Board of Directors Secretary-General, China Social Survey by the deputy director of the National Women's Federation, "the Chinese economic success of the World Expo" preparatory group responsible person. China's current development strategy study will be director of the Center for Strategic Management Consulting, Jinling Hotel Corporation of independent directors, Alcoa Aluminum Co., Ltd., Jiangsu often independent directors.

Zhao Henglin, male, 61 years old, college educated, senior engineer. Has presided over the formulation of the "August 5," the pharmaceutical industry enterprise management planning; modern enterprise management framework; pharmaceutical industry-standard large-scale industrial planning; organized for the pharmaceutical industry one, two enterprises to be; organization has prepared more than 200 million characters of "Pharmaceutical Enterprises Introduction of modern management ", the ministerial level of outstanding books second prize. Involved in securities by the State Council Office, the Commission for Restructuring the Economy, Planning Commission, the Economic Commission chaired by the pilot joint-stock enterprises relevant to the work of theory, policy research and development, and organized the formulation of the pharmaceutical industry shares the pilot enterprises related industrial policies and establishing a modern enterprise system Pilot programme in the pharmaceutical industry as a national joint-stock transformation of the first batch of pilot enterprises sector, the pharmaceutical industry enterprises organize and implement domestic A-share market 18 companies listed on the stock; outside Hong Kong, Singapore two companies listed on the stock. As the industry during the period from the departments in charge of policy formulation, submitted for approval. Intermediaries election trial, the stock market and so on, presided over the whole work. Organization of the medicines, medical equipment system of declaration of state bond projects, the project proposal was made by the State Council for approval through a five-year total investment of 8.8 billion yuan project, and organized a nationwide audit and implementation. Former director of the Ministry of Health Medical Devices Authority Section officer, technicians, in the State Pharmaceutical Administration Bureau offices, enterprises and the market Management Division, General Secretary for Economic Services, policies and regulations served as Deputy Director of Secretary, Director, Deputy Director of the State Food and Drug Supervision Drug Certification Authority management centre deputy director (deputy secretaries), the State Food and Drug Administration's Office (Planning Division of Finance) Deputy Ombudsman (Deputy Secretary). Of the China Association executive director of the medical equipment, China Brand Strategy Promotion Committee of the Beijing Listed Companies Association Deputy Secretary-General.

Zhang Cheng, male, 63 years old, college educated, senior engineer. Former Red Star Machinery Changfuchangzhang Yangquan in Shanxi Province, Yangquan City Chief of Science and Technology Commission, Yangquan City director of the Institute of Applied Technology, head of Yangquan City suburb, the regional party committee secretary, member of the Standing Committee of Yangquan city, Deputy Mayor, Deputy Economic and Trade Commission in Shanxi Province Director, deputy secretary of the Party Group, in Shanxi Province Economic and Trade Commission, and party branch secretary of the Shanxi Province People's Congress Standing Committee, Legislative Committee chairman. Shanxi technological transformation of the current president of the Association, promote Shanxi old vice president, Shanxi professional managers, vice president of the Association, the Association of Shanxi, vice president of legal construction, Shanxi University of Finance and Economics Professor, Tsinghua University Alumni Association, vice president of the Shanxi branch.

Liu Junyan, male, 42 years old, Dr. Management (accounting direction). Main research directions: enterprise financial management, financial accounting, securities investment, capital markets, corporate governance, financial analysis, budgeting, accounting and other non-profit organizations. Representatives of major works: "financial management" and "accounting basis", "Government and the institutions of accounting", "research institutions accounting theory", "On the financial management mechanism," "fund-raising management." Major research projects: 1997 State Science and Technology Commission issues "budget accounting reform", in 1999 the PLA General Logistics Department issues, "the military hospital accounting systems and regulations," 2003 National Social Science Fund topic "based on the interests of the controlling shareholders of listed companies in China equity research ", In 2004 the Ministry of Finance issues" Government Accounting Standards research. " In the accounting of the Chinese People's University to teach; Chinese People's University School of Business accounting department to teach. Of the China People's University Business School Associate Professor of the Department of Accounting, Inc. in the home buyers of independent directors.

Annex 3:

Shanxi Asia-Pharmaceutical Group Co., Ltd.

Independent director nominees statement

Shanxi nominees Asia-Pharmaceutical Group Co., Ltd. Board of Directors on the nomination Feng Chen, Zhang Cheng, Liu Junyan, Zhao Henglin for the Shanxi-the fourth-Pharmaceutical Group Co., Ltd. board of directors independent candidate issued a public statement, Nominees with the Shanxi-Asia Group Co., Ltd. between medicine and there is no impact on the independence of the nominees, specifically the following statement:

The nomination was fully aware of the nominees occupation, education, job title, detailed work experience, all part-time and other circumstances of the (nominees detailed curriculum vitae see Annex), who has been nominated as written consent of the Shanxi-medicine Industry Group Co., Ltd. fourth independent board of directors candidates (with: an independent director candidates statement), the nominee that the nominees

1, in accordance with laws, administrative regulations and other relevant regulations, as have the qualifications of the directors of listed companies;

Second, with Shanxi Pharmaceutical Group Co., Ltd.-Asia provisions of the charter service;

Third, with the China Securities Regulatory Commission "in a listed company on the establishment of an independent director system of guidance on" the independence required by:

1, the nominees and their immediate families, mainly social relations are not in Shanxi Asia-Pharmaceutical Group Co., Ltd. and its affiliates serve;

2, the nominees and their immediate families are not direct or indirect holders of the listed companies have issued shares of 1 percent of the shareholders, nor is it the top ten shareholders of listed companies;

3, the nominees and their immediate families are not directly or indirectly, holders of the issued shares of listed companies has more than 5 percent of the units as shareholders, not in the top five shareholders of listed companies as units;

4, was nominated in the last year is not included in the above three cases;

5, the nominees are not the listed company and its subsidiaries provide financial, legal, management consulting, technology and consulting service personnel.

4, including Shanxi Asia-Pharmaceutical Group Co., Ltd., the nominees of independent directors who number of listed companies not more than five.

The nominees ensure that the above statement true, complete and accurate, there are no false statements or misleading, the nominees fully understand the making of false statements may result in consequence.

Nominations: Shanxi Asia-Pharmaceutical Group Co., Ltd. Board of Directors

June 3, 2008 in Ruicheng

Shanxi Asia-Pharmaceutical Group Co., Ltd.

Independent director candidates statement

Statements were Feng Chen, as Shanxi Pharmaceutical Group Co., Ltd. Asia-fourth independent board of directors candidates, is now a public statement and I Shanxi Asia-Pharmaceutical Group Co., Ltd. in between I was elected during the company's independent directors do not guarantee I have any impact on the independence of the relationship between the specific issue the following statement:

I, I and my immediate family members, the main social relations is not the company or its subsidiaries serve;

Second, I and my immediate family members have no direct or indirect holders of the company's issued shares of 1 per cent or more;

Third, I and my immediate family members instead of the top ten shareholders of the company;

4, I and my immediate family members are not directly or indirectly, holders of the company's issued shares of 5% or 5% of the units as shareholders;

5, I and my immediate family members are not shareholders of the company's top five office units;

6, I do not have the last year before the five cases cited by;

7, I did not the company or its subsidiary companies to provide financial, legal, management consulting, technology and consulting service;

8, I am not from the listed company and its major shareholders or interested agencies and an additional staff, has not been disclosed to other interests;

9, I meet the requirements of the company's charter service conditions.

In addition, including Shanxi Asia-Pharmaceutical Group Co., Ltd., I independent directors who number of listed companies not more than five.

I am fully aware of the duties of independent directors to ensure that the above statement true, complete and accurate, there are no false statements or misleading, I fully understand that making false statements may result in consequences. Shanghai Stock Exchange could be the basis of this statement I confirm the qualifications and independence. I am in the company as an independent director, will comply with the China Securities Regulatory Commission issued rules and regulations, regulations, and the Shanghai Stock Exchange notified the requirements of business rules and accept the supervision of the Shanghai Stock Exchange, to ensure that sufficient time and energy to perform their duties and make an independent Judging from the major shareholder of the company, the actual control or other companies with existing interests of the unit or individual impact.

Statement: Feng Chen

May 29, 2008 in Ruicheng

Shanxi Asia-Pharmaceutical Group Co., Ltd.

Independent director candidates statement

Zhang Cheng statement people, as Shanxi Pharmaceutical Group Co., Ltd. Asia-fourth independent board of directors candidates, is now a public statement and I Shanxi Asia-Pharmaceutical Group Co., Ltd. in between I was elected during the company's independent directors do not guarantee I have any impact on the independence of the relationship between the specific issue the following statement:

I, I and my immediate family members, the main social relations is not the company or its subsidiary companies serve;

Second, I and my immediate family members have no direct or indirect holders of the company's issued shares of 1 per cent or more;

Third, I and my immediate family members instead of the top ten shareholders of the company;

4, I and my immediate family members are not directly or indirectly, holders of the company's issued shares of 5% or 5% of the units as shareholders;

5, I and my immediate family members are not shareholders of the company's top five office units;

6, I do not have the last year before the five cases cited by;

7, I did not the company or its subsidiary companies to provide financial, legal, management consulting, technology and consulting service;

8, I am not from the listed company and its major shareholders or interested agencies and an additional staff, has not been disclosed other interests;

9, I meet the requirements of the company's charter service conditions.

In addition, including Shanxi Asia-Pharmaceutical Group Co., Ltd., I independent directors who number of listed companies not more than five.

I am fully aware of the duties of independent directors to ensure that the above statement true, complete and accurate, there are no false statements or misleading, I fully understand that making false statements may result in consequences. Shanghai Stock Exchange could be the basis of this statement I confirm the qualifications and independence. I serve as the company's independent directors, will comply with the China Securities Regulatory Commission issued rules and regulations, regulations, and the Shanghai Stock Exchange notified the requirements of business rules and accept the supervision of the Shanghai Stock Exchange, to ensure that sufficient time and energy to perform their duties and make an independent Judging from the major shareholder of the company, the actual control or other companies with existing interests of the unit or individual impact.

Statement: Zhang Cheng

June 2, 2008 in Ruicheng

Shanxi Asia-Pharmaceutical Group Co., Ltd.

Independent director candidates statement

Statements were Liu Junyan, as Shanxi Pharmaceutical Group Co., Ltd. Asia-fourth independent board of directors candidates, is now a public statement and I Shanxi Asia-Pharmaceutical Group Co., Ltd. in between I was elected during the company's independent directors do not guarantee I have any impact on the independence of the relationship between the specific issue the following statement:

I, I and my immediate family members, the main social relations is not the company or its subsidiary companies serve;

Second, I and my immediate family members have no direct or indirect holders of the company's issued shares of 1 per cent or more;

Third, I and my immediate family members instead of the top ten shareholders of the company;

4, I and my immediate family members are not directly or indirectly, holders of the company's issued shares of 5% or 5% of the units as shareholders;

5, I and my immediate family members are not shareholders of the company's top five office units;

6, I do not have the last year before the five cases cited by;

7, I did not the company or its subsidiary companies to provide financial, legal, management consulting, technology and consulting service;

8, I am not from the listed company and its major shareholders or interested agencies and an additional staff, has not been disclosed to other interests;

9, I meet the requirements of the company's charter service conditions.

In addition, including Shanxi Asia-Pharmaceutical Group Co., Ltd., I independent directors who number of listed companies not more than five.

I am fully aware of the duties of independent directors to ensure that the above statement true, complete and accurate, there are no false statements or misleading, I fully understand that making a false statement may lead to results. Shanghai Stock Exchange could be the basis of this statement I confirm the qualifications and independence. I serve as the company's independent directors, will comply with the China Securities Regulatory Commission issued rules and regulations, regulations, and the Shanghai Stock Exchange notified the requirements of business rules and accept the supervision of the Shanghai Stock Exchange, to ensure that sufficient time and energy to perform their duties and make an independent Judging from the major shareholder of the company, the actual control or other companies with existing interests of the unit or individual impact.

Statement: Liu Junyan

June 1, 2008 in Beijing

Shanxi Asia-Pharmaceutical Group Co., Ltd.

Independent director candidates statement

Zhao Henglin statement people, as Shanxi Pharmaceutical Group Co., Ltd. Asia-fourth independent board of directors candidates, is now a public statement and I Shanxi Asia-Pharmaceutical Group Co., Ltd. I was between the independent directors of the company during the guarantee I do not have any impact on the independence of the relationship between the specific issue the following statement:

I, I and my immediate family members, the main social relations is not the company or its subsidiary companies serve;

Second, I and my immediate family members have no direct or indirect holders of the company's issued shares of 1 per cent or more;

Third, I and my immediate family members instead of the top ten shareholders of the company;

4, I and my immediate family members are not directly or indirectly, holders of the company's issued shares of 5% or 5% of the units as shareholders;

5, I and my immediate family members are not shareholders of the company's top five office units;

6, I do not have the last year before the five cases cited by;

7, I did not the company or its affiliated enterprises to provide financial, legal, management consulting, technology and consulting service;

8, I am not from the listed company and its major shareholders or interested agencies and an additional staff, has not been disclosed to other interests;

9, I meet the requirements of the company's charter service conditions.

In addition, including Shanxi Asia-Pharmaceutical Group Co., Ltd., I concurrently independent directors of listed companies is not the number of over 5.

本人完全清楚独立董事的职责，保证上述声明真实、完整和准确，不存在任何虚假陈述或误导成分，本人完全明白作出虚假声明可能导致的后果。上海证券交易所可依据本声明确认本人的任职资格和独立性。本人在担任该公司独立董事期间，将遵守中国证监会发布的规章、规定、通知以及上海证券交易所业务规则的要求，接受上海证券交易所的监管，确保有足够的时间和精力履行职责，作出独立判断，不受公司主要股东、实际控制人或其他与公司存在利害关系的单位或个人的影响。

声明人：赵恒林

２００８年５月３０日于北京

证券代码：６００３５１ 股票简称：亚宝药业编号：２００８－临１４号

山西亚宝药业集团股份有限公司

第三届监事会第十二次会议决议公告

本公司及监事会全体成员保证公告内容的真实、准确和完整，对公告的虚假记载、误导性陈述或者重大遗漏负连带责任。

山西亚宝药业集团股份有限公司第三届监事会第十二次会议于２００８年６月３日在风陵渡经济开发区公司总部会议室召开，会议应到监事５人，实到监事４人，监事樊宏宾因公出差委托监事杜占代为出席会议并行使表决权，符合《公司法》及《公司章程》的有关规定。会议由公司监事会主席赵保义先生主持，公司审议并经表决一致通过了如下决议：

一、审议通过了关于监事会换届选举的议案；

本公司第三届监事会经２００５年５月２６日召开的２００４年度股东大会选举产生，任期三年，现已任期届满，根据公司法及公司章程的有关规定，应予以换届，经对相关人员任职资格进行审核，现提名白丽媛、杜占为公司第四届监事会监事候选人。

（监事候选人简历见附件）

二、审议通过了关于修改公司章程的议案。

以上两项议案均需提交公司２００７年度股东大会审议通过。

特此公告

山西亚宝药业集团股份有限公司监事会

２００８年６月４日

附件：

监事候选人简历

白丽媛，女，４４岁，大学学历，经济师。曾任山西省经济建设投资公司副处长，本公司第一届、第二届监事会监事。现任山西省经济建设投资公司副处长，本公司监事。

杜占，男，４５岁，大学学历，注册会计师，审计师。曾任芮城县审计局企业股股长，本公司审计办主任。现任本公司监事、副总经济师。
中国证券报

Lianyungang Ideal Group Co., Ltd. 2008 5th annual board meeting of the first resolution notice – Information Centre – Finance

Securities Code: 000626 securities referred to: Ruyi Group Notice No. :2008-007

Lianyungang Ideal Group Co., Ltd. 5th Board

The first meeting of the year 2008 resolution Notice

Board of Directors of the Company and all members of the contents of the notice true, accurate and complete, no false records, misleading statements or major omissions.

Lianyungang Ideal Group Co., Ltd. at its fifth annual board of directors of the first meeting of 2008 on June 3, 2008 held, 11 should go to director, is the director of 11, including: Director Mr. Li Bingyuan, Miss Chen Honghui, white Xinhua President commissioned by the directors of Mr. Peng Liang, director of Mr. Liu Yongjun commissioned by the directors of Mr. Zhao Liangxing, the independent directors of Miss Wu Jianwei, Mr. Wu Ge commissioned by the independent directors, Mr. Wei and India attended the meeting and vote on the company board of supervisors to observe the meeting. After careful consideration of the participants and fully discussed, the motion to vote on the following:

First, Zhejiang Grand Import and Export Co., Ltd. to a wholly owned subsidiary – lofty International (Hong Kong) Limited to increase the registered capital, from 100,000 U.S. dollars to 1 million U.S. dollars (see companies in the June 4, 2008 in the "China Securities News "," the Securities Times "and the giant tidal information network http://www.cninfo.com.cn published in the" Foreign Investment Notice ").

The voting was: agree with 11 votes against 0, with abstentions none.

The result of the voting: through.

Second, "Lianyungang Ideal Group Co., Ltd. Annual Report of the independent directors of the system."

The voting was: agree with 11 votes against 0, with abstentions none.

The result of the voting: through.

Three, "Lianyungang Ideal Group Co., Ltd. board of directors of the Board of Auditors report a point of order."

The voting was: agree with 11 votes against 0, with abstentions none.

The result of the voting: through.

Fourth, Mr. Liu Dong, vice president due to personal reasons for requesting changes in the work resigned from the vice president.

The voting was: agree with 11 votes against 0, with abstentions none.

The result of the voting: through.

Miss Wu Jianwei of independent directors, and India, Mr. Wei, Mr. Wu Ge, Ge Zhiliang President of the resolution agreed.

5, a decision on June 26, 2008 held 2007 Annual General Meeting (see companies in the June 4, 2008 in "China Securities News", "the Securities Times" and the giant tidal information network http://www.cninfo . Com.cn published in the notice of meeting).

The voting was: agree with 11 votes against 0, with abstentions none.

The result of the voting: through.

It is hereby announced.

Lianyungang Ideal Group Co., Ltd. Board of Directors

June 4, 2008

Securities Code: 000626 securities referred to: Ruyi Group Notice No. :2008-008

Lianyungang Ideal Group Co., Ltd. Board of Directors

On the convening of the 2007 annual shareholder meeting notice

Board of Directors of the Company and all members of the disclosure of the contents of the information true, accurate, complete, no false records, misleading statements or material omissions.

After June 3, 2008 at the Lianyungang Ideal Group Co., Ltd. at its fifth year of 2008 the Board considered the first meeting, decided on June 26, 2008 held 2007 annual shareholder meeting, the following key elements:

(A) held a meeting basic conditions

1, the meeting: June 26, 2008 10:00 AM.

2, the meeting place: the Company Conference Room.

3, convener of the meeting: the Board of the Company.

4, stock registration: June 20, 2008.

5, held by: voting at the scene.

6, at Target:

(1) deadline for June 20, 2008 at the end of the afternoon trading in the China Securities Clearing limited liability company registered in the Shenzhen Branch of the shareholders of the Company or its legal commission agents;

(2) The Company directors, supervisors and senior management.

(B) the consideration of matters

1,2007 annual report and summary of the text.

2,2007 annual report on the work of the Board of Trustees.

3,2007 annual report on the work of the board of supervisors.

4,2007 annual profit distribution programme: Jiangsu value CPA Ltd. audit confirmed that the deadline of 31 December 2007 Japanese companies for the distribution of profits is negative, so companies do not extract the year 2007 the statutory reserve fund, not the year for 2007 Distribution of profits, not a capital surplus Zhuanzengguben.

(C) of the registration method

Corporate shareholders requested a copy of a business license, unit recommendation letters, Shenzhen shareholders account cards, identity cards and were authorized to attend power of attorney; natural shareholders holding my ID card, account cards and Shenzhen shareholders holding that (entrusted with the present, Also authorized holding power of attorney and client and the trustee ID), on June 23, 2008 – Jun 25 9:00 am to 11:00 pm and 2:00 to 4:00 pm to the Board of the Company Secretariat to register, meeting the same day can also be registered. Remote shareholders may be registered letter or fax.

(D) Other matters

1, Contact: Tan Wei Tel :0518-85153595 Fax :0518-85150105; Address: Lianyungang City, Jiangsu Province, northwest Xinpu Qu Road on the 6th; Postal Code: 222006.

2, the participating shareholders or agents of their own transport and accommodation costs.

We would like to inform.

Lianyungang Ideal Group Co., Ltd. Board of Directors

June 4, 2008

By-laws: authorized power of attorney

Client securities accounts: the number of principal shareholders:

Commissioned date:

Securities Code: 000626 securities referred to: Ruyi Group Notice No. :2008-009

Lianyungang Ideal Group Co., Ltd.

Notice Board of foreign investment

Board of Directors of the Company and all members of the contents of the notice true, accurate and complete, no false records, misleading statements or major omissions.

The Lianyungang Ideal Group Co., Ltd. on June 3, 2008, held its fifth year of 2008 the Board of Trustees considered the first meeting, agreed to Zhejiang Grand Import and Export Co., Ltd. wholly owned subsidiary – lofty International (Hong Kong) Limited increase Registered capital, from 100,000 U.S. dollars to 1 million U.S. dollars.

1, the transaction outlined

Zhejiang Grand Import and Export Co., Ltd. to its wholly-owned subsidiaries – lofty International (Hong Kong) Limited to increase the registered capital, from 100,000 U.S. dollars to 1 million U.S. dollars.

Second, the Import and Export Company Limited and Zhejiang lofty vision International (Hong Kong) Ltd. The basic conditions

Zhejiang Grand Import and Export Co., Ltd. of the Company holds 52 percent stake in the holding subsidiaries, the registered capital of 80 million yuan, mainly business and agents of the state commodity import and export business, technology import and export business, barter trade and entrepot trade. As of December 31, 2007 total assets of 2,639,656,385.32 yuan, the net assets of 297,280,303.12 yuan in 2007, revenue from principal operations 13,031,020,650.48 Yuan, the main business profits 487,913,737.20 yuan, net profit 107,198,190.15 yuan.

Great International (Hong Kong) Ltd. of Zhejiang Grand wholly-owned subsidiary of the Import and Export Co., Ltd., was established in August 2007, registered in Hong Kong, China, the registered capital of 100,000 U.S. dollars, mainly engaged in various types of merchandise import and export trade. 2007 lofty international sales income 15.625 million U.S. dollars, the main business profits 1.142 million U.S. dollars, net profit of 773,000 U.S. dollars.

Third, the basic conditions of transactions

Great International (Hong Kong) Limited original registered capital of 100,000 U.S. dollars, and foreign trade bank issuing the higher margin requirements, and the Hong Kong market, inter-industry competition is particularly fierce, so the company decided to study, Zhejiang Grand Import and Export Co., Ltd. to its own funds To the ambitious international replenishment of 900,000 U.S. dollars, after the capital increase registered capital by lofty international 100,000 U.S. dollars changed to 1 million U.S. dollars, the company used for normal business.

Fourth, the impact of transactions

Zhejiang Grand Import and Export Co., Ltd. to its wholly-owned subsidiaries – lofty International (Hong Kong) Limited to increase the registered capital, is beneficial to easing foreign banks issuing margin pressure on the international vision to further expand markets, develop marketing channels, for more The international customers, and ensure the steady growth of the company benefits is of great significance.

It is hereby announced.

Lianyungang Ideal Group Co., Ltd. Board of Directors

June 4, 2008 China Securities News